Literature DB >> 31473605

New potential players in hepcidin regulation.

Maxwell Chappell1, Stefano Rivella2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31473605      PMCID： PMC6717596          DOI： 10.3324/haematol.2019.224311

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  The hemochromatosis proteins HFE, TfR2, and HJV form a membrane-associated protein complex for hepcidin regulation.

Authors:  Flavia D'Alessio; Matthias W Hentze; Martina U Muckenthaler
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

2.  Combination of Tmprss6- ASO and the iron chelator deferiprone improves erythropoiesis and reduces iron overload in a mouse model of beta-thalassemia intermedia.

Authors:  Carla Casu; Mariam Aghajan; Paraskevi Rea Oikonomidou; Shuling Guo; Brett P Monia; Stefano Rivella
Journal:  Haematologica       Date:  2015-09-24       Impact factor: 9.941

Review 3.  New strategies to target iron metabolism for the treatment of beta thalassemia.

Authors:  Paraskevi Rea Oikonomidou; Carla Casu; Stefano Rivella
Journal:  Ann N Y Acad Sci       Date:  2016-02-25       Impact factor: 5.691

4.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

Authors:  Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

5.  Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).

Authors:  Karin E Finberg; Matthew M Heeney; Dean R Campagna; Yeşim Aydinok; Howard A Pearson; Kip R Hartman; Mary M Mayo; Stewart M Samuel; John J Strouse; Kyriacos Markianos; Nancy C Andrews; Mark D Fleming
Journal:  Nat Genet       Date:  2008-04-13       Impact factor: 38.330

6.  Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation.

Authors:  Huiyong Chen; Tenzin Choesang; Huihui Li; Shuming Sun; Petra Pham; Weili Bao; Maria Feola; Mark Westerman; Guiyuan Li; Antonia Follenzi; Lionel Blanc; Stefano Rivella; Robert E Fleming; Yelena Z Ginzburg
Journal:  Haematologica       Date:  2015-12-03       Impact factor: 9.941

7.  Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.

Authors:  Antonella Nai; Aude Rubio; Alessandro Campanella; Ophélie Gourbeyre; Irene Artuso; Jessica Bordini; Aurélie Gineste; Chloé Latour; Céline Besson-Fournier; Herbert Y Lin; Hélène Coppin; Marie-Paule Roth; Clara Camaschella; Laura Silvestri; Delphine Meynard
Journal:  Blood       Date:  2016-01-11       Impact factor: 22.113

8.  Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload?

Authors:  Marco Rausa; Alessia Pagani; Antonella Nai; Alessandro Campanella; Maria Enrica Gilberti; Pietro Apostoli; Clara Camaschella; Laura Silvestri
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

9.  Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB.

Authors:  Thomas Sonnweber; David Nachbaur; Andrea Schroll; Manfred Nairz; Markus Seifert; Egon Demetz; David Haschka; Anna-Maria Mitterstiller; Axel Kleinsasser; Martin Burtscher; Susanne Trübsbach; Anthony T Murphy; Victor Wroblewski; Derrick R Witcher; Katarzyna Mleczko-Sanecka; Chiara Vecchi; Martina U Muckenthaler; Antonello Pietrangelo; Igor Theurl; Günter Weiss
Journal:  Gut       Date:  2014-03-05       Impact factor: 23.059

10.  Identification of erythroferrone as an erythroid regulator of iron metabolism.

Authors:  Léon Kautz; Grace Jung; Erika V Valore; Stefano Rivella; Elizabeta Nemeth; Tomas Ganz
Journal:  Nat Genet       Date:  2014-06-01       Impact factor: 38.330
View more
  3 in total

1.  Characterization of acquired anemia in children by iron metabolism parameters.

Authors:  Yael Ben-David; Ariel Koren; Raul Colodner; Carina Levin
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

2.  SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.

Authors:  Ute Schaeper; George Grigoriadis; Jim Vadolas; Garrett Z Ng; Kai Kysenius; Peter J Crouch; Sibylle Dames; Mona Eisermann; Tiwaporn Nualkaew; Shahla Vilcassim
Journal:  Br J Haematol       Date:  2021-05-04       Impact factor: 6.998

3.  A farewell to phlebotomy-use of placenta-derived drugs Laennec and Porcine for improving hereditary hemochromatosis without phlebotomy: a case report.

Authors:  Yuki Hamada; Eiichi Hirano; Koji Sugimoto; Keizo Hanada; Taiichi Kaku; Naoki Manda; Kenichi Tsuchida
Journal:  J Med Case Rep       Date:  2022-01-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.